Current and historical daily PE Ratio for GRFS (
Grifols
) from 2011 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Grifols stock (GRFS) PE ratio as of Apr 26 2024 is 22.93.
More Details
Grifols SA (GRFS) PE Ratio (TTM) Chart
Grifols SA (GRFS) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1216
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Grifols PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-26 | 22.9 | 2024-02-22 | 31.1 |
| 2024-04-25 | 22.4 | 2024-02-21 | 31.3 |
| 2024-04-24 | 22.8 | 2024-02-20 | 30.5 |
| 2024-04-23 | 23.1 | 2024-02-16 | 30.3 |
| 2024-04-22 | 22.5 | 2024-02-15 | 30.8 |
| 2024-04-19 | 22.4 | 2024-02-14 | 31.0 |
| 2024-04-18 | 23.4 | 2024-02-13 | 30.0 |
| 2024-04-17 | 23.5 | 2024-02-12 | 30.0 |
| 2024-04-16 | 24.2 | 2024-02-09 | 29.6 |
| 2024-04-15 | 23.4 | 2024-02-08 | 29.1 |
| 2024-04-12 | 23.4 | 2024-02-07 | 29.1 |
| 2024-04-11 | 23.8 | 2024-02-06 | 30.0 |
| 2024-04-10 | 24.9 | 2024-02-05 | 30.4 |
| 2024-04-09 | 25.6 | 2024-02-02 | 29.2 |
| 2024-04-08 | 26.0 | 2024-02-01 | 28.7 |
| 2024-04-05 | 25.3 | 2024-01-31 | 28.7 |
| 2024-04-04 | 24.5 | 2024-01-30 | 29.5 |
| 2024-04-03 | 24.6 | 2024-01-29 | 28.8 |
| 2024-04-02 | 24.2 | 2024-01-26 | 28.6 |
| 2024-04-01 | 23.9 | 2024-01-25 | 27.3 |
| 2024-03-28 | 23.9 | 2024-01-24 | 27.4 |
| 2024-03-27 | 23.8 | 2024-01-23 | 26.3 |
| 2024-03-26 | 23.1 | 2024-01-22 | 25.6 |
| 2024-03-25 | 22.7 | 2024-01-19 | 24.1 |
| 2024-03-22 | 22.2 | 2024-01-18 | 24.1 |
| 2024-03-21 | 24.2 | 2024-01-17 | 24.2 |
| 2024-03-20 | 22.5 | 2024-01-16 | 26.2 |
| 2024-03-19 | 21.6 | 2024-01-12 | 25.1 |
| 2024-03-18 | 21.6 | 2024-01-11 | 28.4 |
| 2024-03-15 | 21.9 | 2024-01-10 | 33.0 |
| 2024-03-14 | 20.6 | 2024-01-09 | 31.1 |
| 2024-03-13 | 22.6 | 2024-01-08 | 39.8 |
| 2024-03-12 | 22.5 | 2024-01-05 | 39.5 |
| 2024-03-11 | 24.2 | 2024-01-04 | 40.6 |
| 2024-03-08 | 25.0 | 2024-01-03 | 40.3 |
| 2024-03-07 | 20.0 | 2024-01-02 | 39.5 |
| 2024-03-06 | 19.5 | 2023-12-29 | 41.3 |
| 2024-03-05 | 22.0 | 2023-12-28 | 37.6 |
| 2024-03-04 | 23.7 | 2023-12-27 | 46.5 |
| 2024-03-01 | 25.2 | 2023-12-26 | 46.7 |
| 2024-02-29 | 26.8 | 2023-12-22 | 47.0 |
| 2024-02-28 | 33.4 | 2023-12-21 | 47.4 |
| 2024-02-27 | 33.2 | 2023-12-20 | 47.2 |
| 2024-02-26 | 33.2 | 2023-12-19 | 47.4 |
| 2024-02-23 | 32.6 | 2023-12-18 | 45.6 |
Grifols SA (GRFS) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Grifols SA
NAICS : 325412
ISIN : US3984384087
Share Class Description:
GRFS: ADRDescription
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers